EDGAR Filing Documents for 0001193125-20-137674

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-20-137674

Filing Date

2020-05-08

Accepted

2020-05-08 17:02:01

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d901687ds3.htm	S-3	473242
2	EX-4.4	d901687dex44.htm	EX-4.4	297483
3	EX-4.6	d901687dex46.htm	EX-4.6	95832
4	EX-4.7	d901687dex47.htm	EX-4.7	104343
5	EX-4.8	d901687dex48.htm	EX-4.8	90291
6	EX-5.1	d901687dex51.htm	EX-5.1	28405
7	EX-23.1	d901687dex231.htm	EX-23.1	1687
8	GRAPHIC	g901687g07e55.jpg	GRAPHIC	39955
9	GRAPHIC	g901687snap0002.jpg	GRAPHIC	3390
	Complete submission text file	0001193125-20-137674.txt		1148041

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005

Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631

Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)